Literature DB >> 2742511

The intracellular uptake and protracted release of exogenous heparins by cultured endothelial cells.

L M Hiebert1, N M McDuffie.   

Abstract

Heparins from bovine or porcine sources were fed in media for 48 hrs to cultured porcine aortic and human umbilical vein endothelial cells. Heparin was found in pericellular and cellular fractions after extraction by chemical methods and 125I radiolabelled heparins were recovered when radiolabelled heparin was included in the feed. Even after washing and media changes heparin was detected in media and cell fractions up to 6 days post feeding. Metachromatic vacuoles within cells were demonstrated histologically up to 7 days post feeding after staining with toluidine blue. This is the first report of protracted internalization of exogenous heparin by cultured endothelial cells with concurrent prolonged release of the heparin to the media. This clearly demonstrates that the endothelium plays an important role in the distribution and metabolism of heparin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742511

Source DB:  PubMed          Journal:  Artery        ISSN: 0098-6127


  5 in total

1.  Tissue average binding and equilibrium distribution: an example with heparin in arterial tissues.

Authors:  M A Lovich; E R Edelman
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

2.  Desulphation of dextran sulphate during kidney ultrafiltration.

Authors:  W D Comper; M Tay; X Wells; J Dawes
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

3.  Heparin protects human endothelial cells infected by Rickettsia rickettsii.

Authors:  D J Silverman; L A Santucci; Z Sekeyova
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Movement of heparins across rat gastric mucosa is dependent on molecular weight and pH.

Authors:  Bita Moazed; Linda M Hiebert
Journal:  Pharm Res       Date:  2008-10-21       Impact factor: 4.200

Review 5.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.